Algert Global LLC Ascendis Pharma A/S Transaction History

Algert Global LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$121.07 - $153.67 $93,223 - $118,325	770 Added 54.61%	2,180 $297,000
Q1 2024 May 14, 2024	BUY	$123.45 - $159.4 $174,064 - $224,754	1,410 New	1,410 $213,000
Q1 2023 May 12, 2023	BUY	$104.9 - $126.78 $291,517 - $352,321	2,779 New	2,779 $298,000
Q1 2021 May 14, 2021	SELL	$124.92 - $173.33 $944,395 - $1.31 Million	-7,560 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$151.2 - $182.76 $246,153 - $297,533	-1,628 Reduced 17.72%	7,560 $1.26 Million
Q3 2020 Nov 16, 2020	BUY	$134.29 - $154.32 $187,200 - $215,122	1,394 Added 17.89%	9,188 $1.42 Million
Q2 2020 Aug 12, 2020	SELL	$110.87 - $156.01 $300,679 - $423,099	-2,712 Reduced 25.81%	7,794 $1.15 Million
Q1 2020 May 13, 2020	BUY	$97.01 - $145.11 $1.02 Million - $1.52 Million	10,506 New	10,506 $1.18 Million

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.